While Transmedics Group Inc has overperformed by 2.58%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, TMDX rose by 14.67%, with highs and lows ranging from $177.37 to $67.77, whereas the simple moving average fell by -33.97% in the last 200 days.
On November 22, 2024, Needham Downgraded Transmedics Group Inc (NASDAQ: TMDX) to Hold. A report published by Oppenheimer on October 29, 2024, Reiterated its previous ‘Outperform’ rating for TMDX. Needham also reiterated TMDX shares as ‘Buy’, quoting a target price of $109 on the company’s shares in a report dated October 29, 2024. Robert W. Baird Initiated an Outperform rating on September 24, 2024, and assigned a price target of $200. Needham initiated its ‘Buy’ rating for TMDX, as published in its report on August 21, 2024. Cantor Fitzgerald’s report from June 06, 2024 suggests a price prediction of $161 for TMDX shares, giving the stock a ‘Overweight’ rating. Stephens also rated the stock as ‘Overweight’.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Analysis of Transmedics Group Inc (TMDX)
Further, the quarter-over-quarter increase in sales is 63.72%, showing a positive trend in the upcoming months.
There are several well-rounded types of analysis and research techniques that can be used to gain a clear view of Transmedics Group Inc’s future performance, with equity being one of the most critical indicators. The goal here is to ensure that your current return on equity of 19.41% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 7.33, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
As an indicator of volatility for any stock, average volume can also be very valuable, and TMDX is recording an average volume of 1.57M. On a monthly basis, the volatility of the stock is set at 6.19%, whereas on a weekly basis, it is put at 5.34%, with a loss of -2.79% over the past seven days. Furthermore, long-term investors anticipate a median target price of $123.88, showing growth from the present price of $80.61, which can serve as yet another indication of whether TMDX is worth investing in or should be passed over.
How Do You Analyze Transmedics Group Inc Shares?
Transmedics Group Inc (TMDX) is based in the USA and is one of the most prominent companies operating in the Medical Devices market. When comparing Transmedics Group Inc shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 86.36, there is a growth in quarterly earnings of 115.16%.
Apart from looking at the fundamentals, you should also pay attention to the number of company employees who own shares. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 3.35%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 109.96% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
TMDX shares are owned by institutional investors to the tune of 109.96% at present.
